200
Participants
Start Date
December 31, 2006
Primary Completion Date
August 31, 2008
Study Completion Date
August 31, 2008
Mirabegron
oral
Placebo
oral
Garden City
Virginia Beach
Winston-Salem
Tallahassee
Cincinnati
Des Moines
Shreveport
Tuscon
Culver City
Torrance
San Diego
Fresno
Atherton
Middlebury
Watertown
Victoria
Victoria
Winnipeg
Saint John
Halifax
Kitchener
Toronto
Chicoutimi
Chicoutimi
Montreal
Pointe-Claire
Sherbrooke
Lead Sponsor
Astellas Pharma Inc
INDUSTRY